Date: 2011-11-15
Type of information: Services contract
Compound: clinical development services
Company: UCB (Belgium) Parexel (USA) PRA (USA)
Therapeutic area:
Type agreement: clinical development
Action mechanism:
Disease:
Details: UCB has entered into strategic partnerships with PAREXEL and PRA to drive UCB’s operational clinical development activities. The agreements are effective for all of UCB’s new clinical study programs on a global basis.
Financial terms:
Latest news:
